Chemkart India was incorporated on March 06, 2020. The company supplies a wide range of nutritional, health, and sports supplement ingredients for the B2B market. Its product portfolio includes amino acids, proteins, vitamins, herbal extracts, and other nutrition-focused components. It operates a blending and grinding facility in Maharashtra to customize formulations as per client needs
| Bidding Dates |
|---|
| 07 Jul 2025 - 09 Jul 2025 |
| Subscription |
|---|
| 5.56x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹2,83,200 | 2 | 2 | 600 | 3.2 M | ₹236 - ₹248 | 73.31 % | ₹762.1 M - ₹800.8 M | RHP DOC |
Chemkart IPO SUBSCRIPTION STATUS
09 Jul '25Chemkart IPO overall subscription rate was 5.56 times the total available shares
Chemkart IPO retail subscription rate was 2.17 times in the retail segment
Chemkart IPO non-institutional investor subscription rate was 7.99 times in the non-institutional investor category
Chemkart IPO Qualified Institutional Bidder subscription rate was 7.2 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
09 Jul 2025 (Day 3) | 2.17x | 7.99x | 7.2x |
08 Jul 2025 (Day 2) | 0.34x | 2.96x | 1.79x |
07 Jul 2025 (Day 1) | 0.13x | 1.94x | 0.42x |
Chemkart FINANCIALS
| Period | Net Profit (Rs in crore) | Revenue from Operations (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY25 | 24.3 | 203.3 | 4.0 | -0.1 | 16.1% |
| FY24 | 14.5 | 132.0 | 0.0 | -0.2 | 15.8% |
| FY23 | 7.7 | 131.4 | 0.1 | -5.2 | 8.4% |
Chemkart IPO SUBSCRIPTION STATUS DETAILS
Chemkart had 3.2 M shares on offer
Chemkart IPO offer price was in the range ₹236 - ₹248
Chemkart IPO minimum Investment was ₹283200
Chemkart IPO issue size was ₹ 762.1 M - ₹ 800.8 M
Chemkart had a minimum lot size of 600 Shares per application
Chemkart NUMBER OF SHARES ON OFFER
Chemkart IPO IMPORTANT DATES
| Issue Open Date | 07 Jul 2025 |
| Issue close Date | 09 Jul 2025 |
| Allotment Date | 10 Jul 2025 |
| Refund Date | 11 Jul 2025 |
| Demat Account Credit Date | 11 Jul 2025 |
| Listing Date | 14 Jul 2025 |
| Listing on Exchange(s) | BSE |
| Chemkart Allotment Status | Exchange/ Registrar |
Chemkart IPO subscription opened on 07 Jul 2025, and closed on 09 Jul 2025
IPO allotment for Chemkart was finalized on Thursday, 10 Jul 2025
IPO listing for Chemkart was on BSE on Monday, 14 Jul 2025
Chemkart IPO LISTING GAINS
| Issue Price (adjusted) | 248.0 |
| Listing Open Price | 250.0 |
| Listing Close Price | 259.4 |
| Listing Gain% | 0.8% |
| Current Gain% | -19.4% |
Chemkart Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemkart India Ltd. | 199.9 | 241.9 | 12.3 | -0.6 | 1.1 | 15.2 | 12.5 | 215.5 | 4.9 | 19.7 | -19 | 16.2 | -19 |
| Nestle India Ltd. | 1528.6 | 294762.1 | 77.3 | 3.4 | 12.1 | 67.8 | 26.5 | 23195 | 14.5 | 3499.1 | 9.1 | 19.8 | 22.6 |
| Britannia Industries Ltd. | 5623.5 | 135452.3 | 52 | 2.8 | 6.9 | 49.6 | 26 | 19375.6 | 6.6 | 2533.5 | 16.3 | 108.1 | 18.7 |
| Hatsun Agro Products Ltd. | 952.9 | 21225.7 | 57 | 2.5 | 2 | 18.3 | 8 | 9972.9 | 14.8 | 356.2 | 24.8 | 16.7 | 22.9 |
| Zydus Wellness Ltd. | 516.1 | 16420.3 | 87.2 | -2.1 | 3.6 | 3.4 | 1.9 | 3967.4 | 45.7 | 197.2 | -43.2 | 5.9 | -42.5 |
| Bikaji Foods International Ltd. | 623.3 | 15628.4 | 60.5 | 2.2 | 5.1 | 16.1 | 11.5 | 3045.3 | 14.7 | 258.3 | 28.6 | 10.3 | 27.9 |
Chemkart INFORMATION ON IPO ISSUE
About Chemkart
Chemkart India was incorporated on March 06, 2020. The company supplies a wide range of nutritional, health, and sports supplement ingredients for the B2B market. Its product portfolio includes amino acids, proteins, vitamins, herbal extracts, and other nutrition-focused components. It operates a blending and grinding facility in Maharashtra to customize formulations as per client needs
Object of the Issue
- Financing the capital expenditure towards setting up of the manufacturing facility through investment in the wholly-owned subsidiary, Easy Raw Materials
- Repayment/prepayment of all or certain of the borrowings
- General corporate purposes
Chemkart - PROMOTERS
| Name |
|---|
| Ankit Shailesh Mehta |
| Parul Shailesh Mehta |
| Shailesh Vinodrai Mehta |
Chemkart Book Running Lead Manager
Smart Horizon Capital Advisors Private Limited
director@shcapl.com
Chemkart Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Chemkart Strengths
Diversified product portfolio
The company offers a wide range of nutraceutical products across categories such as amino acids, herbal extracts, proteins, vitamins, health supplements, nucleotides, and sports nutrition. These products are available in various packaging sizes, allowing the company to cater to a broad set of customer preferences
In-house infrastructure capability
The company's warehousing and processing facility in Bhiwandi, Mumbai is equipped for blending, grinding, packing, labelling, and sealing nutraceutical ingredients. Supported by trained staff and skilled contract labourers, the setup ensures hygienic handling and efficient processing of large-volume orders
Strong customer value
The company operates in the B2B segment and focuses on developing long-term relationships with a wide customer base. It believes sustained engagement and consistent delivery build trust, enabling strong retention and repeat business
Chemkart Risks
Geographic sourcing risk
The company sources most of its domestic raw materials from Maharashtra. This geographic concentration increases exposure to regional disruptions, including regulatory changes, supply chain issues, and demographic shifts
Supplier dependence risk
A significant portion of the company’s supply is reliant on its top 5 and top 10 suppliers, with no long-term or exclusive contracts in place. Disruptions in supply, whether due to non-performance or termination of relationships, could affect production continuity and overall profitability
Regional sales dependence
The company derives a major share of its domestic sales from Maharashtra, Gujarat, and New Delhi, with limited international presence. This regional concentration makes it susceptible to localized economic or regulatory changes
IPO FAQs
This IPO consists of an offer for sale of up to Rs 15.6 crore, of 629,200 shares. It also consists of a fresh issue of Rs 64.5 crore.
The promoters of the company are Ankit Shailesh Mehta, Parul Shailesh Mehta and Shailesh Vinodrai Mehta.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 236.0 - 248.0.
The IPO application opens on Jul 07, 2025 and closes on Jul 09, 2025.
The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.
For all category investors, the minimum application amount for this IPO is Rs. 283,200.0, the maximum value for this IPO is Rs 297,600.0.
This IPO will be allotted on Jul 10, 2025.
The refund will be credited to your account on Jul 11, 2025.
The allotted shares will be credited to your demat on Jul 11, 2025.
Chemkart India Ltd.’s shares listed on the stock exchanges on Jul 14, 2025.